ASH 2018: Dr. Woyach on ibrutinib with or without rituximab versus bendamustine plus rituximab
By Brian Koffman, MD This is really big news. Practice changing news. Dr. Jennifer Woyach of Ohio State presented the results of the large phase III Alliance A041202 collaborative multi-centered trial that